Calamos Advisors’s Trine II Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share TRAQ.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-742,892
Closed -$18.6K 1183
2023
Q1
$18.6K Hold
742,892
﹤0.01% 1010
2022
Q4
$59.4K Buy
+742,892
New +$45K ﹤0.01% 979

Calamos Advisors's TRAQ.WS Position: Q2 2023 in Review

Calamos Advisors sold out of Trine II Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share (TRAQ.WS) in Q2 2023, closing a stake of 742,892 shares — an estimated $18.6K sold.

Calamos Advisors first reported a position in TRAQ.WS in Q4 2022 and held it in 2 quarters. The position peaked at $59.4K in Q4 2022. 0 funds tracked by Wall St. Rank hold TRAQ.WS as of Q2 2023.

  • Calamos Advisors reported no remaining Trine II Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share position as of Q2 2023 after selling out during the quarter.
  • Calamos Advisors sold 742,892 Trine II Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share shares in Q2 2023, an estimated $18.6K.
  • Calamos Advisors first reported a position in Trine II Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share in Q4 2022 and held it in 2 quarters.
  • Calamos Advisors's Trine II Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share position peaked at $59.4K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Trine II Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share as of Q2 2023.

Based on Calamos Advisors's 13F filing for Q2 2023, filed 28 Jul 2023.